Compared with vehicle-treated CLP mice, recombinant Nrg4 (rNrg4) administration markedly improved survival rates (Fig. 6a) and reduced MSS, indicating alleviation of sepsis symptoms (Fig. 6b). The gene discussed is NRG4; the disease is Sepsis.